"clinical development"

#8927430

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927436

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927438

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927440

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927442

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927444

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927446

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927462

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8927470

30 September 2022

KYIV, UKRAINE - SEPTEMBER 28, 2022 - On of the initiative of the Embassy of Israel in Ukraine and the Israeli Agency for International Development Cooperation MASHAV, a ceremony of handing over medical equipment to the Kyiv City Children's Clinical Hospital no.2 is held in Kyiv, capital of Ukraine.NO USE RUSSIA. NO USE BELARUS.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6321504

4 January 2021

Dr.Saptashi Basu,Physician with protective gear at front of Woodland Hospital ,In the latest development on the health of BCCI president Sourav Ganguly, the Woodlands hospital in Kolkata where he is admitted said that further angioplasty for the former Indian Skipper will be done later, with the date yet to be decided, and that he will likely be released from hospital day after tomorrow, i.e. on Wednesday. Ganguly was rushed to the hospital on Saturday after he complained of chest discomfort, heaviness of head and vomiting. Mr Sourav Ganguly 48 years/ Bed no- 516 Under care- Dr Saroj Mandal, Dr Soutik Panda, Dr Saptarshi Basu Medical board of 9 members met today at 1130am with reputed specialists on zoom platform Dr Saroj Mondal Dr Aftab Khan Dr SB Roy Dr Saptarshi Basu Dr Bhabatosh Biswas Dr Soutik Panda Dr Asish Patra Dr Palash Kumar Dr Malti Purkait Dr Rupali Basu Dr Devi Shetty ( on zoom ) Dr RK Panda ( on zoom ) Dr Samuel Mathew ( on phone) Opinions were taken from Dr Aswin Mehta ( Jaslok Mumbai) and Dr Shamin K Sharma ( Mount Sinai NY) The medical records and his clinical condition of Mr Sourav Ganguly were reviewed by the board members. The unanimous decision was that an appropriate timely excellent treatment of primary PTCA with revascularisation of RCA was rendered during the acute heart attack stage. The discussion was also on the two other coronary blockages viz LAD and OM2 need to be treated by angioplasty in this admission vis a vis doing it at a immediate later stage. The consensus of the board was that deferring the angioplasty for now is deemed to be a safer option since Mr Ganguly is stable, without any chest pain and is on optimal medical management. The family members were present during the board meeting and were explained about the disease process and further therapeutic plan. in Kolkata,On January 04,2021.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274256

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274258

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274260

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274262

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274264

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274266

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.